Administration, Evaluation, and Planning

行政规划和评价核心，即核心A，对孢子的成功至关重要。伊丽莎白·格林博士是总的核心主任，并由三名联席主任协助，其中包括创始联席主任杰弗里·E·李博士，他将主持执行委员会会议，会议将由所有共同主任和每个项目和核心的一名领导人组成。两位新的联合董事包括Patrick Hwu，M.D.，AS 临床试验资源主任，目前将被合并为Core A的一部分；以及Jeffrey E.Gershenwald医学博士，作为患者信息学和肿瘤获取和分发的总体主任。我们的执行委员会将每月开会，审查科学进展和财政状况，并将帮助克服问题或障碍，以确保在现实的时间框架内和在预算限制内实现所有目标。该行政核心将安排与调查人员的所有会议，并确保最佳 与M.D.安德森癌症中心和其他地方的调查人员进行沟通。所有孢子调查员将参加每周的黑色素瘤研讨会，并定期向内部咨询委员会报告进展情况。一个外部咨询委员会将通过在休斯顿举行的年度会议或通过网络/视频或电话会议评估所有孢子研究方案的现状和进展。具体责任 核心A包括 *遵守所有一般、政府和NCI法规和要求。 *与NCI进行沟通和协商，以编制所有必要的报告和 出版物。 *协调数据控制质量保证问题 *监督和支持信息学、组织资源和病理学核心B。 *临床试验管理资源在此优化临床试验工作 核心A。 *维持财政和预算职能，并管理资金的灵活性。 *召开孢子行政会议，包括执行委员会、 内部和外部咨询委员会，每周科学会议，每季度 研究会议、讲座和座谈会。 *发展研究和职业发展方案的管理。 *协调和资助患者代言人活动。 *制定和监测招募妇女和少数民族的政策 程序。 *与其他孢子网站协调，通过赞助和/或参加每年一次的皮肤孢子会议，以及通过分享和分发材料、电子通信和评估进展报告，促进和保持沟通和融合。

The Administrative Planning and Evaluation Core, Core A, is critical to the success of the SPORE. Dr. Elizabeth Grimm is the overall Core Director, and is assisted by three Co-Directors, including the founding Co-Director, Dr. Jeffrey E. Lee, who will chair the Executive Committee meetings which will be composed of all Co-PIs and one leader from each Project and Core. Two new co-directors include Patrick Hwu, M.D., as director of the Clinical Trials Resource which for now will be incorporated as part of Core A; and Jeffrey E. Gershenwald, M.D., as overall director of patient informatics and tumor acquisition and distribution. Our Executive Committee will meet monthly to review scientific progress and fiscal status and will help surmount problems or barriers to assure that all goals are met within a realistic timeframe and within the budget constraints. This Administrative Core will schedule all meetings with investigators and assure optimum communication with investigators at M.D. Anderson Cancer Center and elsewhere. All SPORE investigators will participate in weekly melanoma seminars and regulariy report progress to the Internal Advisory Committee. An External Advisory Committee will evaluate status and progress of all SPORE research programs by annual meetings either in Houston or by web/video or teleconference. Specific responsibilities of Core A include * Compliance with all general, governmental and NCI regulations and requirements. * Communication and consultation with the NCI in preparation of all required reports and publications. * Coordination of data control quality assurance issues * Oversight and support for the Informatics, Tissue Resource and Pathology Core B. * Optimization of clinical trial efforts by a Clinical Trials Management Resource in this Core A. * Maintenance of fiscal and budgetary functions, and managing flexibility in funding. * Convene SPORE Administrative meetings, including the Executive Committee, the Internal and External Advisory Committees, weekly scientific meetings, quarteriy research meetings, lectures, and symposia. * Administration of the Developmental Research and Career Development Programs. * Coordination and Funding of Patient Advocate activities. * Establishment and monitoring of policies for recruitment of women and minorities of this program. * Coordination with other SPORE sites to promote and maintain communication and integration through sponsoring and/or attending a yeariy Skin SPORE conference, and also through sharing and distribution of materials, electronic communications, and evaluation of progress reports.